MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
1.160
-0.080
-6.45%
Pre Market: 1.142 -0.019 -1.59% 08:25 10/23 EDT
OPEN
1.160
PREV CLOSE
1.240
HIGH
1.220
LOW
1.115
VOLUME
16.88K
TURNOVER
0
52 WEEK HIGH
1.790
52 WEEK LOW
0.1952
MARKET CAP
121.81M
P/E (TTM)
-1.7946
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
PDS Biotechnology highlights oncology pipeline and PDS0301 progress
TipRanks · 2d ago
PDS Biotechnology Reshapes Board with New Director Appointments
TipRanks · 3d ago
Press Release: PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors
Dow Jones · 3d ago
Press Release: PDS Biotechnology Appoints Three -2-
Dow Jones · 3d ago
Weekly Report: what happened at PDSB last week (1012-1016)?
Weekly Report · 4d ago
Pantginis Reiterates Buy on PDS Biotechnology, Maintains $5 Price Target as PDS0301 Data and Phase 3 Plans De‑Risk Program
TipRanks · 10/15 15:55
PDS Biotechnology registers to sell 16.5M shares of common stock for holders
TipRanks · 10/14 20:20
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration, and longevity of T cells in the tumor microenvironment. Its Versamune immunotherapies and Versamune in combination with PDS01ADC, are utilized for treatments in oncology, and Infectimune is utilized for preventive vaccines against infectious agents.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.